Transcriptome profiling of adipose tissue reveals depot-specific metabolic alterations among colorectal cancer patients.
暂无分享,去创建一个
J. Böhm | N. Habermann | P. Schrotz-King | C. Ulrich | H. Kauczor | H. Brenner | P. Schirmacher | A. Benner | E. Herpel | H. Glimm | D. Scherer | C. Ball | J. Nattenmüller | R. Toth | B. Gigic | A. Ulrich | B. Straub | Martin A Schneider | Mariam Haffa | A. Holowatyj | M. Kratz | Tengda Lin | Martin Schneider
[1] M. Migaldi,et al. Radiotherapy-induced mesorectum alterations: histological evaluation of 90 consecutive cases , 2015, Scandinavian journal of gastroenterology.
[2] G. Colditz,et al. The Plausibility of Obesity Paradox in Cancer-Point. , 2018, Cancer research.
[3] T. McLaughlin,et al. Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity. , 2011, The Journal of clinical endocrinology and metabolism.
[4] Michael J Thun,et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.
[5] J. Böhm,et al. Body Fatness, Adipose Tissue Compartments, and Biomarkers of Inflammation and Angiogenesis in Colorectal Cancer: The ColoCare Study , 2018, Cancer Epidemiology, Biomarkers & Prevention.
[6] P. Froguel,et al. Tenomodulin is highly expressed in adipose tissue, increased in obesity, and down-regulated during diet-induced weight loss. , 2009, The Journal of clinical endocrinology and metabolism.
[7] J. Murabito,et al. Fat quality and incident cardiovascular disease, all-cause mortality, and cancer mortality. , 2015, The Journal of clinical endocrinology and metabolism.
[8] C. Aguilar-Salinas,et al. High adiponectin concentrations are associated with the metabolically healthy obese phenotype. , 2008, The Journal of clinical endocrinology and metabolism.
[9] M. Leblanc,et al. Association between Body Mass Index and Cancer Survival in a Pooled Analysis of 22 Clinical Trials , 2016, Cancer Epidemiology, Biomarkers & Prevention.
[10] C. Ulrich,et al. Effects of intermittent and continuous calorie restriction on body weight and metabolism over 50 wk: a randomized controlled trial. , 2018, The American journal of clinical nutrition.
[11] Xin Wang,et al. Bioinformatics Applications Note Systems Biology Htsanalyzer: an R/bioconductor Package for Integrated Network Analysis of High-throughput Screens , 2022 .
[12] Dominique Scherer,et al. Signals from the Adipose Microenvironment and the Obesity–Cancer Link—A Systematic Review , 2017, Cancer Prevention Research.
[13] J. Vague,et al. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. , 1956, The American journal of clinical nutrition.
[14] Y. Bossé,et al. Gene expression variability in subcutaneous and omental adipose tissue of obese men. , 2007, Gene expression.
[15] B. Caan,et al. The Importance of Body Composition in Explaining the Overweight Paradox in Cancer-Counterpoint. , 2018, Cancer research.
[16] T. Hudson,et al. A survey of genes differentially expressed in subcutaneous and visceral adipose tissue in men. , 2004, Obesity research.
[17] D. Loskutoff,et al. Monocyte chemoattractant protein 1 in obesity and insulin resistance , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[18] J. Després,et al. Abdominal obesity and metabolic syndrome , 2006, Nature.
[19] M. Gunter,et al. Adiposity and gastrointestinal cancers: epidemiology, mechanisms and future directions , 2018, Nature Reviews Gastroenterology & Hepatology.
[20] S. B. Pedersen,et al. 11β‐HSD Type 1 Expression in Human Adipose Tissue: Impact of Gender, Obesity, and Fat Localization , 2007, Obesity.
[21] J. Böhm,et al. The ColoCare Study: A Paradigm of Transdisciplinary Science in Colorectal Cancer Outcomes , 2018, Cancer Epidemiology, Biomarkers & Prevention.
[22] Michael J. Thomas,et al. SAA: a link between cholesterol efflux capacity and inflammation?1 , 2015, Journal of Lipid Research.
[23] M. Caligiuri,et al. Obesity, Inflammation, and Cancer. , 2016, Annual review of pathology.
[24] E. Maury,et al. Adipokines oversecreted by omental adipose tissue in human obesity. , 2007, American journal of physiology. Endocrinology and metabolism.
[25] J. Stevens,et al. Selection of measures in epidemiologic studies of the consequences of obesity , 2008, International Journal of Obesity.
[26] E. Calle,et al. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms , 2004, Nature Reviews Cancer.
[27] Petra C. Schwalie,et al. Insights into negative regulation by the glucocorticoid receptor from genome-wide profiling of inflammatory cistromes. , 2013, Molecular cell.
[28] M. Serlie,et al. Obesity activates a program of lysosomal-dependent lipid metabolism in adipose tissue macrophages independently of classic activation. , 2013, Cell metabolism.
[29] P. Schrotz-King,et al. Inflammation- and angiogenesis-related biomarkers are correlated with cancer-related fatigue in colorectal cancer patients: Results from the ColoCare Study. , 2019, European journal of cancer care.
[30] L. Lönn,et al. The expression of NAD(P)H:quinone oxidoreductase 1 is high in human adipose tissue, reduced by weight loss, and correlates with adiposity, insulin sensitivity, and markers of liver dysfunction. , 2007, The Journal of clinical endocrinology and metabolism.
[31] R Guardo,et al. Quantification of adipose tissue by MRI: relationship with anthropometric variables. , 1992, Journal of applied physiology.
[32] K. Fearon,et al. The role of body composition evaluation by computerized tomography in determining colorectal cancer treatment outcomes: a systematic review. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[33] B. Caan,et al. Visceral adiposity and cancer survival: a review of imaging studies , 2018, European journal of cancer care.
[34] C. Bouchard,et al. Clinical utility of visceral adipose tissue for the identification of cardiometabolic risk in white and African American adults. , 2013, The American journal of clinical nutrition.
[35] L. Oyama,et al. Peritumoural adipose tissue pro‐inflammatory cytokines are associated with tumoural growth factors in cancer cachexia patients , 2018, Journal of cachexia, sarcopenia and muscle.
[36] A. Rossi,et al. Morphological and Functional Changes in the Peritumoral Adipose Tissue of Colorectal Cancer Patients , 2017, Obesity.
[37] C. Roberts,et al. Depot-specific differences in inflammatory mediators and a role for NK cells and IFN-γ in inflammation in human adipose tissue , 2009, International Journal of Obesity.
[38] C. Beglinger,et al. Insulin resistance causes inflammation in adipose tissue , 2018, The Journal of clinical investigation.
[39] E. Barrett-Connor,et al. Insulin-like growth factor-I and cancer mortality in older men. , 2010, The Journal of clinical endocrinology and metabolism.
[40] C. Fox,et al. Association between single-slice measurements of visceral and abdominal subcutaneous adipose tissue with volumetric measurements: the Framingham Heart Study , 2010, International Journal of Obesity.
[41] A. Saltiel,et al. Adapting to obesity with adipose tissue inflammation , 2017, Nature Reviews Endocrinology.
[42] Cheng Cheng,et al. Sample size determination for the false discovery rate , 2005, Bioinform..
[43] B. Ludvik,et al. CC chemokine and CC chemokine receptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity. , 2008, The Journal of clinical endocrinology and metabolism.
[44] G. Rojo-Martínez,et al. Altered Expression of miR-181a-5p and miR-23a-3p Is Associated With Obesity and TNF&agr;-Induced Insulin Resistance , 2018, The Journal of clinical endocrinology and metabolism.
[45] Jürgen Böhm,et al. Metabolomics and transcriptomics identify pathway differences between visceral and subcutaneous adipose tissue in colorectal cancer patients: the ColoCare study. , 2015, The American journal of clinical nutrition.
[46] U. Nöthlings,et al. Postdiagnosis body mass index and risk of mortality in colorectal cancer survivors: a prospective study and meta-analysis , 2014, Cancer Causes & Control.
[47] Caroline S. Fox,et al. The Framingham Heart Study — 67 years of discovery in metabolic disease , 2016, Nature Reviews Endocrinology.
[48] M. Bauer,et al. Glucocorticoid receptor dimerization is required for survival in septic shock via suppression of interleukin‐1 in macrophages , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[49] Youyi Fong,et al. Rank-based two-sample tests for paired data with missing values. , 2018, Biostatistics.
[50] M. Prentki,et al. Increased subcutaneous adipose tissue expression of genes involved in glycerolipid-fatty acid cycling in obese insulin-resistant versus -sensitive individuals. , 2014, The Journal of clinical endocrinology and metabolism.
[51] G. Frühbeck,et al. IL-32α-induced inflammation constitutes a link between obesity and colon cancer , 2017, Oncoimmunology.
[52] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[53] R. Lehner,et al. Chemotherapy diminishes lipid storage capacity of adipose tissue in a preclinical model of colon cancer , 2017, Lipids in Health and Disease.
[54] U. Turpeinen,et al. Estrogen Metabolism in Abdominal Subcutaneous and Visceral Adipose Tissue in Postmenopausal Women , 2017, The Journal of clinical endocrinology and metabolism.
[55] S. B. Pedersen,et al. Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. , 2005, The Journal of clinical endocrinology and metabolism.
[56] P. Schrotz-King,et al. CT-based compartmental quantification of adipose tissue versus body metrics in colorectal cancer patients , 2016, European Radiology.
[57] B. Spiegelman,et al. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.
[58] P. Svensson,et al. Expression of GHR and Downstream Signaling Genes in Human Adipose Tissue-Relation to Obesity and Weight Change. , 2018, The Journal of clinical endocrinology and metabolism.
[59] J. Reynolds,et al. Pro-inflammatory and tumour proliferative properties of excess visceral adipose tissue. , 2011, Cancer letters.
[60] S. Holm. A Simple Sequentially Rejective Multiple Test Procedure , 1979 .
[61] I. Rogatsky,et al. There goes the neighborhood: Assembly of transcriptional complexes during the regulation of metabolism and inflammation by the glucocorticoid receptor , 2016, Steroids.
[62] K. Straif,et al. Body Fatness and Cancer--Viewpoint of the IARC Working Group. , 2016, The New England journal of medicine.
[63] A. Schafer,et al. Subcutaneous Fat Fibrosis Links Obesity to Insulin Resistance in Chinese Americans , 2018, The Journal of clinical endocrinology and metabolism.
[64] C. Fox,et al. Association Between Visceral and Subcutaneous Adipose Depots and Incident Cardiovascular Disease Risk Factors , 2015, Circulation.
[65] N. Abdella,et al. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes , 2007, International Journal of Obesity.
[66] J. Böhm,et al. Associations Between Dietary Patterns and Longitudinal Quality of Life Changes in Colorectal Cancer Patients: The ColoCare Study , 2018, Nutrition and cancer.
[67] M. Stumvoll,et al. Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. , 2007, The Journal of clinical endocrinology and metabolism.
[68] N. Habermann,et al. Gene Expression Changes in Adipose Tissue with Diet- and/or Exercise-Induced Weight Loss , 2013, Cancer Prevention Research.
[69] D. Gozal,et al. Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages. , 2014, Cell metabolism.
[70] J. Moreno-Navarrete,et al. Decreased STAMP2 expression in association with visceral adipose tissue dysfunction. , 2011, The Journal of clinical endocrinology and metabolism.
[71] S. Delorme,et al. Validation of Anthropometric Indices of Adiposity against Whole-Body Magnetic Resonance Imaging – A Study within the German European Prospective Investigation into Cancer and Nutrition (EPIC) Cohorts , 2014, PloS one.
[72] Wei Shi,et al. BeadArray Expression Analysis Using Bioconductor , 2011, PLoS Comput. Biol..
[73] C. Ulrich,et al. Energy balance and gastrointestinal cancer: risk, interventions, outcomes and mechanisms , 2018, Nature Reviews Gastroenterology & Hepatology.
[74] M. Desai,et al. Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.
[75] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[76] B. Lippitz,et al. Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosis , 2016, Oncoimmunology.
[77] P. Stattin,et al. Obesity and colon cancer: Does leptin provide a link? , 2004, International journal of cancer.
[78] G. Bray,et al. The Relationship of Waist Circumference and BMI to Visceral, Subcutaneous, and Total Body Fat: Sex and Race Differences , 2011, Obesity.
[79] D. Brenner,et al. A Systematic Review of the Effect of Lifestyle Interventions on Adipose Tissue Gene Expression: Implications for Carcinogenesis , 2017, Obesity.
[80] C. Ulrich,et al. Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[81] Udo Hoffmann,et al. Body fat distribution, incident cardiovascular disease, cancer, and all-cause mortality. , 2013, Journal of the American College of Cardiology.
[82] E. Wagner,et al. A switch from white to brown fat increases energy expenditure in cancer-associated cachexia. , 2014, Cell metabolism.
[83] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[84] R. Eils,et al. Comparison of normalization methods for Illumina BeadChip HumanHT-12 v3 , 2010, BMC Genomics.
[85] A. Sekerková,et al. Human adipose tissue accumulation is associated with pro-inflammatory changes in subcutaneous rather than visceral adipose tissue , 2017, Nutrition & Diabetes.
[86] Z. Kováčová,et al. Worsening of obesity and metabolic status yields similar molecular adaptations in human subcutaneous and visceral adipose tissue: decreased metabolism and increased immune response. , 2010, Journal of Clinical Endocrinology and Metabolism.